Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol
Authors:
- Melina MakatsoriMMMelina Makatsori
- Gianenrico SennaGSGianenrico Senna
- Constantinos PitsiosCPConstantinos Pitsios
- Ramon LleonartRLRamon Lleonart
- Ludger KlimekLKLudger Klimek
- Carlos NunesCNCarlos Nunes
- Maia RukhadzeMRMaia Rukhadze
- Barbara RogalaBRBarbara Rogala
- Radoslaw GawlikRGRadoslaw Gawlik
- Petr PanznerPPPetr Panzner
- Oliver PfaarOPOliver Pfaar
- Moises CalderonMCMoises Calderon
Open Access
- 1 January 2015
- journal article
- research article
- Published by Wiley in Clinical and Translational Allergy
- Vol. 5 (1) , 17
Abstract
Background: Adherence to allergen immunotherapy is important for its effectiveness. There is currently limited data available on allergen immunotherapy adherence outside of clinical trials i.e. in real‐life clinical practice. As part of a European Academy of Allergy and Clinical Immunology Immunotherapy Interest group initiative, we endeavoured to design a survey in order to prospectively evaluate adherence to subcutaneous and sublingual immunotherapy across different European countries.Method/Design: The inclusion criteria for this prospective, multi‐country survey were set as: adults, starting clinically indicated allergen immunotherapy for respiratory allergic disorders or Hymenoptera venom allergy. An online survey was designed in order to enrol participants and assess adherence to immunotherapy.Eight countries (Czech Republic, Georgia, Germany, Greece, Italy, Poland, Portugal, Spain) were selected to reflect different parts of Europe and differences in allergens and routes of immunotherapy administration. Each country has an allocated National co‐ordinator that has identified local Allergy departments willing to enrol participants in this survey.Each participant will be followed up for a total of three years. In order to assess adherence, a 4‐monthly follow‐up form detailing any missed doses and reasons will be completed online. In case of a participant discontinuing treatment, reasons for this will be recorded.Discussion: The use of online survey software has enabled us to make this survey a reality and reach clinicians in different countries. Forty‐five centres have enrolled a total of over 1,350 participants. It is hoped that this prospective real life survey will enable us to gain a better understanding of reasons that affect adherence to subcutaneous and sublingual immunotherapy and assist in developing ways to improve this.Keywords
This publication has 45 references indexed in Scilit:
- Treatment of Hymenoptera venom allergyCurrent Opinion in Allergy and Clinical Immunology, 2014
- Dropouts in sublingual allergen immunotherapy trials – a systematic reviewAllergy, 2014
- Costs of treatment affect compliance to specific subcutaneous immunotherapy.2014
- Allergy Immunotherapy Adherence and Delivery Route: Location Does Not MatterThe Journal of Allergy and Clinical Immunology: In Practice, 2014
- A retrospective review of veterans' adherence to allergen immunotherapy over 10 yearsAnnals of Allergy, Asthma & Immunology, 2014
- Adherence to sublingual immunotherapy in preschool childrenPediatric Allergy and Immunology, 2012
- A comparison of attrition rates in patients undergoing sublingual immunotherapy vs subcutaneous immunotherapyInternational Forum of Allergy & Rhinology, 2012
- The Prevalence of Nonadherence in Difficult AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Early Compliance and Efficacy of Sublingual Immunotherapy in Patients with Allergic Rhinitis for House Dust MitesClinical and Experimental Otorhinolaryngology, 2009
- Patient dropouts before completion of optimal dose, multiple allergen immunotherapyAnnals of Allergy, Asthma & Immunology, 1999